Over the last twenty years, the treatment landscape for blood cancers such as leukaemia, lymphoma, and multiple myeloma has undergone a profound and inspiring transformation.
What was once a field shadowed by limited options and uncertain outcomes has today become one of the brightest frontiers in modern oncology.
As someone who has walked this journey alongside countless patients, families, and fellow clinicians, I can say with conviction: we are not merely treating cancer, we are redefining hope.
advertisement
FROM CHEMOTHERAPY TO TARGETED THERAPIES
In the early 2000s, chemotherapy reigned supreme, effe
Continue Reading on India Today
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.